Immucell Corp (ICCC) Reports Q3 Loss of $0.02

Immucell Corp (NASDAQ: ICCC) reported Q3 EPS of ($0.02), versus ($0.04) reported last year. Revenue for the quarter came in at $1.08 million versus the consensus estimate of $1 million.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation